{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:30:42Z","timestamp":1779179442709,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":57,"publisher":"Springer US","isbn-type":[{"value":"9781071613818","type":"print"},{"value":"9781071613825","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1382-5_25","type":"book-chapter","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T05:02:45Z","timestamp":1621832565000},"page":"371-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mouse Models of Skin Fibrosis"],"prefix":"10.1007","author":[{"given":"Aleix","family":"Rius Rigau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Luber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg H. W.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"issue":"19","key":"25_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360(19):1989\u20132003","journal-title":"N Engl J Med"},{"issue":"12","key":"25_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler JHW, Gyorfi AH, Ramanujam M, Whitfield ML, Konigshoff M, Lafyatis R (2019) Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol 15(12):705\u2013730","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"25_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/annrheumdis-2016-209698","volume":"76","author":"R Liang","year":"2017","unstructured":"Liang R, Sumova B, Cordazzo C, Mallano T, Zhang Y, Wohlfahrt T et al (2017) The transcription factor GLI2 as a downstream mediator of transforming growth factor-beta-induced fibroblast activation in SSc. Ann Rheum Dis 76(4):756\u2013764","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"25_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/annrheumdis-2019-215066","volume":"78","author":"R Liang","year":"2019","unstructured":"Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Ramming A et al (2019) Acyltransferase skinny hedgehog regulates TGFbeta-dependent fibroblast activation in SSc. Ann Rheum Dis 78(9):1269\u20131273","journal-title":"Ann Rheum Dis"},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","volume":"208","author":"EF Wagner","year":"2005","unstructured":"Wagner EF, Eferl R (2005) Fos\/AP-1 proteins in bone and the immune system. Immunol Rev 208:126\u2013140","journal-title":"Immunol Rev"},{"issue":"3","key":"25_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/annrheumdis-2014-206214","volume":"75","author":"T Mallano","year":"2016","unstructured":"Mallano T, Palumbo-Zerr K, Zerr P, Ramming A, Zeller B, Beyer C et al (2016) Activating transcription factor 3 regulates canonical TGFbeta signalling in systemic sclerosis. Ann Rheum Dis 75(3):586\u2013592","journal-title":"Ann Rheum Dis"},{"issue":"7744","key":"25_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41586-019-0896-x","volume":"566","author":"T Wohlfahrt","year":"2019","unstructured":"Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A et al (2019) PU.1 controls fibroblast polarization and tissue fibrosis. Nature 566(7744):344\u2013349","journal-title":"Nature"},{"issue":"10","key":"25_CR8","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1002\/art.27647","volume":"62","author":"C Beyer","year":"2010","unstructured":"Beyer C, Schett G, Distler O, Distler JH (2010) Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum 62(10):2831\u20132844","journal-title":"Arthritis Rheum"},{"issue":"5","key":"25_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/1097-0142(1967)20:5<891::AID-CNCR2820200550>3.0.CO;2-V","volume":"20","author":"H Umezawa","year":"1967","unstructured":"Umezawa H, Ishizuka M, Maeda K, Takeuchi T (1967) Studies on bleomycin. Cancer 20(5):891\u2013895","journal-title":"Cancer"},{"issue":"4","key":"25_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0305-7372(83)90012-9","volume":"10","author":"FM Muggia","year":"1983","unstructured":"Muggia FM, Louie AC, Sikic BI (1983) Pulmonary toxicity of antitumor agents. Cancer Treat Rev 10(4):221\u2013243","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"25_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","volume":"112","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H et al (1999) Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112(4):456\u2013462","journal-title":"J Invest Dermatol"},{"issue":"2","key":"25_CR12","doi-asserted-by":"publisher","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","volume":"294","author":"BB Moore","year":"2008","unstructured":"Moore BB, Hogaboam CM (2008) Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294(2):L152\u2013L160","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"25_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s004030000183","volume":"292","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Kuroda M, Nishioka K (2000) Animal model of sclerotic skin. III: histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch Dermatol Res 292(11):535\u2013541","journal-title":"Arch Dermatol Res"},{"issue":"16","key":"25_CR14","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/hmg\/11.16.1855","volume":"11","author":"CK Haston","year":"2002","unstructured":"Haston CK, Wang M, Dejournett RE, Zhou X, Ni D, Gu X et al (2002) Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet 11(16):1855\u20131863","journal-title":"Hum Mol Genet"},{"issue":"2","key":"25_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.0906-6705.2005.00280.x","volume":"14","author":"T Yamamoto","year":"2005","unstructured":"Yamamoto T, Nishioka K (2005) Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp Dermatol 14(2):81\u201395","journal-title":"Exp Dermatol"},{"issue":"6","key":"25_CR16","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","volume":"172","author":"A Yoshizaki","year":"2008","unstructured":"Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E et al (2008) CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 172(6):1650\u20131663","journal-title":"Am J Pathol"},{"issue":"3","key":"25_CR17","first-page":"1185","volume":"243","author":"JH Harrison Jr","year":"1987","unstructured":"Harrison JH Jr, Lazo JS (1987) High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther 243(3):1185\u20131194","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"25_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.bmt.1703111","volume":"28","author":"V Ratanatharathorn","year":"2001","unstructured":"Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP (2001) Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 28(2):121\u2013129","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"25_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","volume":"129","author":"SJ Lee","year":"2017","unstructured":"Lee SJ (2017) Classification systems for chronic graft-versus-host disease. Blood 129(1):30\u201337","journal-title":"Blood"},{"issue":"2","key":"25_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/1078-0432.CCR-15-1443","volume":"22","author":"S Arai","year":"2016","unstructured":"Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N et al (2016) A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation. Clin Cancer Res 22(2):319\u2013327","journal-title":"Clin Cancer Res"},{"issue":"1","key":"25_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","volume":"19","author":"K Strong Rodrigues","year":"2018","unstructured":"Strong Rodrigues K, Oliveira-Ribeiro C, de Abreu Fiuza Gomes S, Knobler R (2018) Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol 19(1):33\u201350","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"25_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0008-8749(83)90001-1","volume":"77","author":"BD Jaffee","year":"1983","unstructured":"Jaffee BD, Claman HN (1983) Chronic graft-versus-host disease (GVHD) as a model for scleroderma, I. Description of model systems. Cell Immunol 77(1):1\u201312","journal-title":"Cell Immunol"},{"issue":"5","key":"25_CR23","first-page":"941","volume":"26","author":"V Rogai","year":"2008","unstructured":"Rogai V, Lories RJ, Guiducci S, Luyten FP, Matucci Cerinic M (2008) Animal models in systemic sclerosis. Clin Exp Rheumatol 26(5):941\u2013946","journal-title":"Clin Exp Rheumatol"},{"key":"25_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/OARRR.S50009","volume":"6","author":"CM Artlett","year":"2014","unstructured":"Artlett CM (2014) Animal models of systemic sclerosis: their utility and limitations. Open Access Rheumatol 6:65\u201381","journal-title":"Open Access Rheumatol"},{"issue":"6","key":"25_CR25","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","volume":"168","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC (2002) Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 168(6):3088\u20133098","journal-title":"J Immunol"},{"key":"25_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fimmu.2018.00963","volume":"9","author":"ESP Santos","year":"2018","unstructured":"Santos ESP, Bennett CL, Chakraverty R (2018) Unraveling the mechanisms of cutaneous graft-versus-host disease. Front Immunol 9:963","journal-title":"Front Immunol"},{"key":"25_CR27","doi-asserted-by":"crossref","unstructured":"Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W et al (2017) An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition. JCI Insight 2(12)","DOI":"10.1172\/jci.insight.92111"},{"issue":"18","key":"25_CR28","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1182\/blood-2015-09-668145","volume":"127","author":"H Jin","year":"2016","unstructured":"Jin H, Ni X, Deng R, Song Q, Young J, Cassady K et al (2016) Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice. Blood 127(18):2249\u20132260","journal-title":"Blood"},{"issue":"4","key":"25_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbmt.2007.12.002","volume":"14","author":"YW Chu","year":"2008","unstructured":"Chu YW, Gress RE (2008) Murine models of chronic graft-versus-host disease: insights and unresolved issues. Biol Blood Marrow Transplant 14(4):365\u2013378","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"25_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/sj.bmt.1702383","volume":"25","author":"S Levy","year":"2000","unstructured":"Levy S, Nagler A, Okon S, Marmary Y (2000) Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model. Bone Marrow Transplant 25(10):1073\u20131078","journal-title":"Bone Marrow Transplant"},{"key":"25_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2015.00167","volume":"6","author":"C Kayser","year":"2015","unstructured":"Kayser C, Fritzler MJ (2015) Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol 6:167","journal-title":"Front Immunol"},{"issue":"3","key":"25_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","volume":"12","author":"S Mehra","year":"2013","unstructured":"Mehra S, Walker J, Patterson K, Fritzler MJ (2013) Autoantibodies in systemic sclerosis. Autoimmun Rev 12(3):340\u2013354","journal-title":"Autoimmun Rev"},{"issue":"11","key":"25_CR33","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/art.30539","volume":"63","author":"A Yoshizaki","year":"2011","unstructured":"Yoshizaki A, Yanaba K, Ogawa A, Asano Y, Kadono T, Sato S (2011) Immunization with DNA topoisomerase I and Freund\u2019s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum 63(11):3575\u20133585","journal-title":"Arthritis Rheum"},{"issue":"3","key":"25_CR34","first-page":"493","volume":"82","author":"MC Green","year":"1976","unstructured":"Green MC, Sweet HO, Bunker LE (1976) Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 82(3):493\u2013512","journal-title":"Am J Pathol"},{"issue":"4","key":"25_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1101\/gr.6.4.300","volume":"6","author":"LD Siracusa","year":"1996","unstructured":"Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ et al (1996) A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 6(4):300\u2013313","journal-title":"Genome Res"},{"issue":"2","key":"25_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/art.1780270209","volume":"27","author":"SA Jimenez","year":"1984","unstructured":"Jimenez SA, Millan A, Bashey RI (1984) Scleroderma-like alterations in collagen metabolism occurring in the TSK (tight skin) mouse. Arthritis Rheum 27(2):180\u2013185","journal-title":"Arthritis Rheum"},{"issue":"4","key":"25_CR37","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1074\/jbc.M209256200","volume":"278","author":"Z Isogai","year":"2003","unstructured":"Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R et al (2003) Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278(4):2750\u20132757","journal-title":"J Biol Chem"},{"issue":"10","key":"25_CR38","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/labinvest.3700331","volume":"85","author":"RM Baxter","year":"2005","unstructured":"Baxter RM, Crowell TP, McCrann ME, Frew EM, Gardner H (2005) Analysis of the tight skin (Tsk1\/+) mouse as a model for testing antifibrotic agents. Lab Invest 85(10):1199\u20131209","journal-title":"Lab Invest"},{"issue":"5","key":"25_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/art.1780340512","volume":"34","author":"MH Bocchieri","year":"1991","unstructured":"Bocchieri MH, Henriksen PD, Kasturi KN, Muryoi T, Bona CA, Jimenez SA (1991) Evidence for autoimmunity in the tight skin mouse model of systemic sclerosis. Arthritis Rheum 34(5):599\u2013605","journal-title":"Arthritis Rheum"},{"issue":"2","key":"25_CR40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1172\/JCI116675","volume":"92","author":"S Shibata","year":"1993","unstructured":"Shibata S, Muryoi T, Saitoh Y, Brumeanu TD, Bona CA, Kasturi KN (1993) Immunochemical and molecular characterization of anti-RNA polymerase I autoantibodies produced by tight skin mouse. J Clin Invest 92(2):984\u2013992","journal-title":"J Clin Invest"},{"issue":"6","key":"25_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1083\/jcb.201002111","volume":"190","author":"A Bozec","year":"2010","unstructured":"Bozec A, Bakiri L, Jimenez M, Schinke T, Amling M, Wagner EF (2010) Fra-2\/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J Cell Biol 190(6):1093\u20131106","journal-title":"J Cell Biol"},{"issue":"1","key":"25_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/annrheumdis-2017-211501","volume":"77","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Brandt A, Merlevede B, Hallenberger L, Dees C, Wohlfahrt T et al (2018) The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis. Ann Rheum Dis 77(1):150\u2013158","journal-title":"Ann Rheum Dis"},{"issue":"30","key":"25_CR43","doi-asserted-by":"publisher","first-page":"10,525","DOI":"10.1073\/pnas.0801414105","volume":"105","author":"R Eferl","year":"2008","unstructured":"Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V et al (2008) Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1. Proc Natl Acad Sci U S A 105(30):10,525\u201310,530","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"25_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/art.38942","volume":"67","author":"P Venalis","year":"2015","unstructured":"Venalis P, Kumanovics G, Schulze-Koops H, Distler A, Dees C, Zerr P et al (2015) Cardiomyopathy in murine models of systemic sclerosis. Arthritis Rheumatol 67(2):508\u2013516","journal-title":"Arthritis Rheumatol"},{"issue":"23","key":"25_CR45","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","volume":"120","author":"B Maurer","year":"2009","unstructured":"Maurer B, Busch N, Jungel A, Pileckyte M, Gay RE, Michel BA et al (2009) Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 120(23):2367\u20132376","journal-title":"Circulation"},{"issue":"12","key":"25_CR46","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/art.1780381212","volume":"38","author":"PJ Christner","year":"1995","unstructured":"Christner PJ, Peters J, Hawkins D, Siracusa LD, Jimenez SA (1995) The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration. Arthritis Rheum 38(12):1791\u20131798","journal-title":"Arthritis Rheum"},{"issue":"3","key":"25_CR47","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/jid.2014.455","volume":"135","author":"KB Long","year":"2015","unstructured":"Long KB, Li Z, Burgwin CM, Choe SG, Martyanov V, Sassi-Gaha S et al (2015) The Tsk2\/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene. J Invest Dermatol 135(3):718\u2013727","journal-title":"J Invest Dermatol"},{"issue":"12","key":"25_CR48","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/1529-0131(199812)41:12<2132::AID-ART8>3.0.CO;2-W","volume":"41","author":"PJ Christner","year":"1998","unstructured":"Christner PJ, Hitraya EG, Peters J, McGrath R, Jimenez SA (1998) Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice. Arthritis Rheum 41(12):2132\u20132142","journal-title":"Arthritis Rheum"},{"issue":"1","key":"25_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/art.22328","volume":"56","author":"S Sonnylal","year":"2007","unstructured":"Sonnylal S, Denton CP, Zheng B, Keene DR, He R, Adams HP et al (2007) Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum 56(1):334\u2013344","journal-title":"Arthritis Rheum"},{"issue":"7","key":"25_CR50","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1136\/annrheumdis-2013-204508","volume":"74","author":"C Beyer","year":"2015","unstructured":"Beyer C, Zenzmaier C, Palumbo-Zerr K, Mancuso R, Distler A, Dees C et al (2015) Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFbeta signalling. Ann Rheum Dis 74(7):1408\u20131416","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"25_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3777","volume":"21","author":"K Palumbo-Zerr","year":"2015","unstructured":"Palumbo-Zerr K, Zerr P, Distler A, Fliehr J, Mancuso R, Huang J et al (2015) Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis. Nat Med 21(2):150\u2013158","journal-title":"Nat Med"},{"issue":"5","key":"25_CR52","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/annrheumdis-2013-204256","volume":"74","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Dees C, Beyer C, Lin NY, Distler A, Zerr P et al (2015) Inhibition of casein kinase II reduces TGFbeta induced fibroblast activation and ameliorates experimental fibrosis. Ann Rheum Dis 74(5):936\u2013943","journal-title":"Ann Rheum Dis"},{"key":"25_CR53","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P et al (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735","journal-title":"Nat Commun"},{"issue":"1","key":"25_CR54","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","volume":"8","author":"D Chakraborty","year":"2017","unstructured":"Chakraborty D, Sumova B, Mallano T, Chen CW, Distler A, Bergmann C et al (2017) Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat Commun 8(1):1130","journal-title":"Nat Commun"},{"issue":"27","key":"25_CR55","doi-asserted-by":"publisher","first-page":"25109","DOI":"10.1074\/jbc.M300636200","volume":"278","author":"CP Denton","year":"2003","unstructured":"Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, Fisher I et al (2003) Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J Biol Chem 278(27):25109\u201325119","journal-title":"J Biol Chem"},{"issue":"16","key":"25_CR56","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1016\/S0021-9258(19)50226-5","volume":"268","author":"T Brand","year":"1993","unstructured":"Brand T, MacLellan WR (1993) Schneider MD. A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J Biol Chem 268(16):11500\u201311503","journal-title":"J Biol Chem"},{"issue":"s1","key":"25_CR57","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0007114517002227","volume":"120","author":"J MacArthur Clark","year":"2018","unstructured":"MacArthur Clark J (2018) The 3Rs in research: a contemporary approach to replacement, reduction and refinement. Br J Nutr 120(s1):S1\u2013S7","journal-title":"Br J Nutr"}],"container-title":["Methods in Molecular Biology","Myofibroblasts"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1382-5_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T05:03:54Z","timestamp":1621832634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1382-5_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071613818","9781071613825"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1382-5_25","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"25 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}